Literature DB >> 2208154

An MDBP site in the first intron of the human c-myc gene.

X Y Zhang1, P C Supakar, K Z Wu, K C Ehrlich, M Ehrlich.   

Abstract

The expression of the human c-myc protooncogene is subject to many levels and types of control. Evidence suggests that regulation of the expression of this gene involves elements within the gene as well as those upstream from the gene. We show that a ubiquitous mammalian sequence-specific DNA-binding protein, MDBP, binds specifically to a site in the beginning of the first intron of this gene. This protein, which binds to certain viral enhancers, may be helping to control expression of the c-myc gene. In some Burkitt lymphomas, which contain activated c-myc genes, the MDBP site is lost by chromosome rearrangement or by multiple spontaneous mutations. This might contribute to cancer-related activation of this protooncogene.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2208154

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Interactions of the transcription factors MIBP1 and RFX1 with the EP element of the hepatitis B virus enhancer.

Authors:  M Blake; J Niklinski; M Zajac-Kaye
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

2.  The transcriptional activation and repression domains of RFX1, a context-dependent regulator, can mutually neutralize their activities.

Authors:  Y Katan; R Agami; Y Shaul
Journal:  Nucleic Acids Res       Date:  1997-09-15       Impact factor: 16.971

3.  The major histocompatibility complex class II promoter-binding protein RFX (NF-X) is a methylated DNA-binding protein.

Authors:  X Y Zhang; N Jabrane-Ferrat; C K Asiedu; S Samac; B M Peterlin; M Ehrlich
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

4.  The myc intron-binding polypeptide associates with RFX1 in vivo and binds to the major histocompatibility complex class II promoter region, to the hepatitis B virus enhancer, and to regulatory regions of several distinct viral genes.

Authors:  W Reinhold; L Emens; A Itkes; M Blake; I Ichinose; M Zajac-Kaye
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

5.  RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins.

Authors:  W Reith; C Ucla; E Barras; A Gaud; B Durand; C Herrero-Sanchez; M Kobr; B Mach
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

6.  Cloning and characterization of a c-myc intron binding protein (MIBP1).

Authors:  R Makino; K Akiyama; J Yasuda; S Mashiyama; S Honda; T Sekiya; K Hayashi
Journal:  Nucleic Acids Res       Date:  1994-12-25       Impact factor: 16.971

7.  A SILAC-based screen for Methyl-CpG binding proteins identifies RBP-J as a DNA methylation and sequence-specific binding protein.

Authors:  Stefanie J J Bartels; Cornelia G Spruijt; Arie B Brinkman; Pascal W T C Jansen; Michiel Vermeulen; Hendrik G Stunnenberg
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

8.  Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk.

Authors:  Dalemari Crowther-Swanepoel; Peter Broderick; Maria Chiara Di Bernardo; Sara E Dobbins; María Torres; Mahmoud Mansouri; Clara Ruiz-Ponte; Anna Enjuanes; Richard Rosenquist; Angel Carracedo; Jesper Jurlander; Elias Campo; Gunnar Juliusson; Emilio Montserrat; Karin E Smedby; Martin J S Dyer; Estella Matutes; Claire Dearden; Nicola J Sunter; Andrew G Hall; Tryfonia Mainou-Fowler; Graham H Jackson; Geoffrey Summerfield; Robert J Harris; Andrew R Pettitt; David J Allsup; James R Bailey; Guy Pratt; Chris Pepper; Chris Fegan; Anton Parker; David Oscier; James M Allan; Daniel Catovsky; Richard S Houlston
Journal:  Nat Genet       Date:  2010-01-10       Impact factor: 38.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.